
Brian D. Badgwell MD
Surgical Oncology (Other than Breast)
Physician
Join to View Full Profile
4301 W Markham St725Little Rock, AR 72205
Phone+1 501-686-5547
Are you Dr. Badgwell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Badgwell, MD is a general surgeon in Little Rock, Arkansas. He is currently licensed to practice medicine in Arkansas, Alabama, and Arizona.
Education & Training
- Ohio State University HospitalResidency, Surgery, 1999 - 2005
- Texas A&M; Health Science Center College of MedicineClass of 1999
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2005 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- American Board of Surgery Surgery
- Join now to see all
Publications & Presentations
PubMed
- Educational Review: Updates on Therapeutic Strategies for Gastric Cancer with Peritoneal Metastasis.Kever A Lewis, Laurence P Diggs, Brian D Badgwell
Annals of Surgical Oncology. 2025-02-27 - 1 citationsPhase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric Cancer.Brian Badgwell, Naruhiko Ikoma, Mariela Blum Murphy, Jenny Li, Xuemei Wang
International Journal of Radiation Oncology, Biology, Physics. 2025-02-01 - Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024.Tae-Han Kim, Ichiro Uyama, Sun Young Rha, Maria Bencivenga, Jiyeong An
Journal of Gastric Cancer. 2025-01-01
Press Mentions
- Should Pre-op Chemoradiation Be Added to Chemotherapy in Resectable Gastric Cancer?October 5th, 2023
- HIPEC for Gastric Cancer: Patient Selection, Recovery Insights, and Guideline RecommendationsMay 22nd, 2024